GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ondine Biomedical Inc (LSE:OBI) » Definitions » Net Margin %

Ondine Biomedical (LSE:OBI) Net Margin % : -1,846.67% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Ondine Biomedical Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Ondine Biomedical's Net Income for the six months ended in Jun. 2023 was £-4.71 Mil. Ondine Biomedical's Revenue for the six months ended in Jun. 2023 was £0.26 Mil. Therefore, Ondine Biomedical's net margin for the quarter that ended in Jun. 2023 was -1,846.67%.

The historical rank and industry rank for Ondine Biomedical's Net Margin % or its related term are showing as below:

LSE:OBI' s Net Margin % Range Over the Past 10 Years
Min: -4471.69   Med: -1342.33   Max: -212.41
Current: -2331.33


LSE:OBI's Net Margin % is ranked worse than
82.57% of 1027 companies
in the Biotechnology industry
Industry Median: -151.78 vs LSE:OBI: -2331.33

Ondine Biomedical Net Margin % Historical Data

The historical data trend for Ondine Biomedical's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ondine Biomedical Net Margin % Chart

Ondine Biomedical Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,471.69 -3,012.27 -908.75 -1,949.97 -3,032.90

Ondine Biomedical Semi-Annual Data
Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -231.94 -7,660.46 -3,274.10 -2,875.77 -1,846.67

Competitive Comparison of Ondine Biomedical's Net Margin %

For the Biotechnology subindustry, Ondine Biomedical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ondine Biomedical's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ondine Biomedical's Net Margin % distribution charts can be found below:

* The bar in red indicates where Ondine Biomedical's Net Margin % falls into.



Ondine Biomedical Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Ondine Biomedical's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-11.707/0.386
=-3,032.90 %

Ondine Biomedical's Net Margin for the quarter that ended in Jun. 2023 is calculated as

Net Margin=Net Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-4.709/0.255
=-1,846.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ondine Biomedical  (LSE:OBI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Ondine Biomedical Net Margin % Related Terms

Thank you for viewing the detailed overview of Ondine Biomedical's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ondine Biomedical (LSE:OBI) Business Description

Traded in Other Exchanges
Address
1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.

Ondine Biomedical (LSE:OBI) Headlines

No Headlines